Abstract:This working paper is hosted by The Berkeley Electronic Press (bepress) and may not be commercially reproduced without the permission of the copyright holder. Summary. Randomized clinical trials are a powerful tool for investigating causal treatment effects, but in human trials there are oftentimes problems of noncompliance which standard analyses, such as the intention-to-treat or as-treated analysis, either ignore or incorporate in such a way that the resulting estimand is no longer a causal effect. One alternative to these analyses is the complier average causal effect (CACE) which estimates the average causal treatment effect among a subpopulation that would comply under any treatment assigned. We focus on the setting of a randomized clinical trial with crossover treatment noncompliance (e.g., control subjects could receive the intervention and intervention subjects could receive the control) and outcome nonresponse. In this article, we develop estimators for the CACE using multiple imputation methods, which have been successfully applied to a wide variety of missing data problems, but have not yet been applied to the potential outcomes setting of causal inference. Using simulated data we investigate the finite sample properties of these estimators as well as of competing procedures in a simple setting. Finally we illustrate our methods using a real randomized encouragement design study on the effectiveness of the influenza vaccine. 1. Introduction The focus of empirical studies in medicine is often to estimate the causal effect of treatments, where randomized clinical trials are considered the most acceptable tool for investigating these causal relationships. But in trials involving human subjects there are oftentimes problems of patient noncompliance, where the patient does not adhere to the treatment assigned. In addition, there is also the problem of nonignorable missing data, where the missing-data mechanism may depend on unobserved data. Standard methods and analyses either ignore these complications, which can lead to biased estimates of causal treatment effect, or account for them in such a way that the resulting estimand can no longer be considered a causal effect of treatment. A statistical framework for causal inference that deals with the issue of noncompliance is based on potential outcomes and was first introduced by Neyman (1923) for randomized studies and later developed by Rubin (1974, 1978) for nonrandomized studies and other forms of inference. Rubin's approach, sometimes referred to as the Ru-bin Causal Model (Holland, 1986), provides a framework for defining the parameters of interest and correctly attributing the …

Amantadine Small-Particle Aerosol: Generation and Delivery to Man

A flexible approach for causal inference with multiple treatments and clustered survival outcomes

Estimation of Causal Effects of Multiple Treatments in Observational Studies with a Binary Outcome

causalCmprsk: An R package for nonparametric and Cox-based estimation of average treatment effects in competing risks data

Matching Algorithms for Causal Inference with Multiple Treatments

Causal Inference with Complex Treatments: A Survey

The Blessings of Multiple Treatments and Outcomes in Treatment Effect Estimation

CausalMetaR: An R package for performing causally interpretable meta-analyses

Multiple-model-based robust estimation of causal treatment effect on a binary outcome with integrated information from secondary outcomes

Matching Estimators for Causal Effects of Multiple Treatments

G-computation, propensity score-based methods, and targeted maximum likelihood estimator for causal inference with different covariates sets: a comparative simulation study

An Inverse Probability Weighted Regression Method that Accounts for Right-censoring for Causal Inference with Multiple Treatments and a Binary Outcome

Theory for identification and Inference with Synthetic Controls: A Proximal Causal Inference Framework

Series 2-19-2009 Multiple Imputation Methods for Treatment Noncompliance and Nonresponse in Randomized Clinical Trials

Multiply Robust Causal Mediation Analysis with Continuous Treatments

Causally interpretable meta-analysis combining aggregate and individual participant data

Estimation of causal effects of multiple treatments in healthcare database studies with rare outcomes

Doubly Robust Proximal Synthetic Controls

A flexible sensitivity analysis approach for unmeasured confounding with multiple treatments and a binary outcome with application to SEER-Medicare lung cancer data

Matching Methods for Causal Inference with Time‐Series Cross‐Sectional Data

Causal effect estimation in survival analysis with high dimensional confounders